Edenred S.A [EDEN] vs Vaziva S.A.S [ALVAZ] Detailed Stock Comparison

Edenred S.A

Vaziva S.A.S
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Edenred S.A wins in 10 metrics, Vaziva S.A.S wins in 4 metrics, with 0 ties. Edenred S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Edenred S.A | Vaziva S.A.S | Better |
---|---|---|---|
P/E Ratio (TTM) | 9.71 | 97.83 | Edenred S.A |
Price-to-Book Ratio | N/A | 6.50 | N/A |
Debt-to-Equity Ratio | -5.11 | 31.65 | Edenred S.A |
EV/EBITDA | 6.96 | 77.94 | Edenred S.A |
Profit Margin (TTM) | 18.94% | 3.04% | Edenred S.A |
Operating Margin (TTM) | 30.47% | -4.89% | Edenred S.A |
EBITDA Margin (TTM) | 30.47% | N/A | N/A |
Return on Equity | -62.67% | 6.79% | Vaziva S.A.S |
Return on Assets (TTM) | 3.92% | 3.29% | Edenred S.A |
Free Cash Flow (TTM) | $812.00M | N/A | N/A |
Dividend Yield | 4.85% | N/A | N/A |
1-Year Return | -43.98% | 15.46% | Vaziva S.A.S |
Price-to-Sales Ratio (TTM) | 1.81 | 3.00 | Edenred S.A |
Enterprise Value | $7.28B | $122.21M | Edenred S.A |
EV/Revenue Ratio | 2.72 | 3.02 | Edenred S.A |
Revenue per Share (TTM) | $11 | $15 | Vaziva S.A.S |
Earnings per Share (Diluted) | $2.07 | $0.46 | Edenred S.A |
Beta (Stock Volatility) | 0.57 | 0.14 | Vaziva S.A.S |
Edenred S.A vs Vaziva S.A.S Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Edenred S.A | 1.79% | 0.80% | -24.77% | -17.51% | -35.50% | -35.46% |
Vaziva S.A.S | 0.45% | 0.00% | -6.28% | -8.20% | -2.18% | -0.88% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Edenred S.A | -43.98% | -57.54% | -47.19% | 24.98% | -13.17% | -13.17% |
Vaziva S.A.S | 15.46% | 113.33% | 103.64% | 103.64% | 103.64% | 103.64% |
News Based Sentiment: Edenred S.A vs Vaziva S.A.S
Edenred S.A
News based Sentiment: NEGATIVE
September was a significantly negative month for Edenred, marked by a substantial stock decline, analyst downgrades, and ongoing regulatory concerns. While the addition of a new board member is a positive step, it was overshadowed by broader market anxieties and a bearish outlook from analysts, indicating a challenging period for the company and its investors.
Vaziva S.A.S
News based Sentiment: MIXED
Vaziva S.A.S. showed impressive revenue growth and client acquisition in the first half of 2025, but the significant stock decline on August 25th introduces a negative element. The company's higher P/S ratio compared to the industry also warrants attention, creating a mixed investment picture.
Performance & Financial Health Analysis: Edenred S.A vs Vaziva S.A.S
Metric | EDEN | ALVAZ |
---|---|---|
Market Information | ||
Market Cap | €4.92B | €121.21M |
Market Cap Category | Large cap | Small cap |
10 Day Avg. Volume | 1,269,020 | 104 |
90 Day Avg. Volume | 785,381 | 155 |
Last Close | €20.47 | €45.00 |
52 Week Range | €19.69 - €36.00 | €32.40 - €50.50 |
% from 52W High | -43.14% | -10.89% |
All-Time High | €62.40 (Jun 12, 2023) | €50.50 (Oct 14, 2024) |
% from All-Time High | -67.20% | -10.89% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.05% | 0.42% |
Quarterly Earnings Growth | 0.00% | N/A |
Financial Health | ||
Profit Margin (TTM) | 0.19% | 0.03% |
Operating Margin (TTM) | 0.30% | -0.05% |
Return on Equity (TTM) | -0.63% | 0.07% |
Debt to Equity (MRQ) | -5.11 | 31.65 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | €-4.87 | €6.92 |
Cash per Share (MRQ) | €12.49 | €1.42 |
Operating Cash Flow (TTM) | €872.00M | €0 |
Levered Free Cash Flow (TTM) | €382.75M | €1.23M |
Dividends | ||
Last 12-Month Dividend Yield | 4.85% | N/A |
Last 12-Month Dividend | €1.21 | N/A |
Valuation & Enterprise Metrics Analysis: Edenred S.A vs Vaziva S.A.S
Metric | EDEN | ALVAZ |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 9.71 | 97.83 |
Forward P/E | 7.73 | N/A |
PEG Ratio | N/A | N/A |
Price to Sales (TTM) | 1.81 | 3.00 |
Price to Book (MRQ) | N/A | 6.50 |
Market Capitalization | ||
Market Capitalization | €4.92B | €121.21M |
Enterprise Value | €7.28B | €122.21M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.72 | 3.02 |
Enterprise to EBITDA | 6.96 | 77.94 |
Risk & Other Metrics | ||
Beta | 0.57 | 0.14 |
Book Value per Share (MRQ) | €-4.87 | €6.92 |
Financial Statements Comparison: Edenred S.A vs Vaziva S.A.S
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | EDEN | ALVAZ |
---|---|---|
Revenue/Sales | N/A | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | N/A | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | EDEN | ALVAZ |
---|---|---|
Cash & Equivalents | €1.59B | €3.80M |
Total Current Assets | €8.55B | €9.44M |
Total Current Liabilities | €9.98B | €3.57M |
Long-Term Debt | €3.98B | €872,958 |
Total Shareholders Equity | €-1.05B | €18.57M |
Retained Earnings | €-1.87B | €1.23M |
Property, Plant & Equipment | €243.00M | €87,013 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | EDEN | ALVAZ |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | EDEN | ALVAZ |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 1,269,020 | 104 |
Average Daily Volume (90 Day) | 785,381 | 155 |
Shares Outstanding | 240.06M | 2.68M |
Float Shares | 226.15M | N/A |
% Held by Insiders | 0.00% | 0.76% |
% Held by Institutions | 0.84% | 0.00% |
Dividend Analysis & Yield Comparison: Edenred S.A vs Vaziva S.A.S
Metric | EDEN | ALVAZ |
---|---|---|
Last 12-Month Dividend | €1.21 | N/A |
Last 12-Month Dividend Yield | 4.85% | N/A |
3-Year Avg Annual Dividend | €1.10 | N/A |
3-Year Avg Dividend Yield | 3.03% | N/A |
3-Year Total Dividends | €3.31 | N/A |
Ex-Dividend Date | Jun 10, 2025 | N/A |